Invention Grant
- Patent Title: Sulfonyl amidine as indoleamine-2,3-dioxygenase inhibitor, and preparation method therefor and use thereof
-
Application No.: US16472077Application Date: 2017-12-22
-
Publication No.: US11370766B2Publication Date: 2022-06-28
- Inventor: Zhe Wang , Zhihong Zeng
- Applicant: SHANGHAI LONGWOOD BIOPHARMACEUTICALS CO., LTD.
- Applicant Address: CN Shanghai
- Assignee: SHANGHAI LONGWOOD BIOPHARMACEUTICALS CO., LTD.
- Current Assignee: SHANGHAI LONGWOOD BIOPHARMACEUTICALS CO., LTD.
- Current Assignee Address: CN Shanghai
- Agency: Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
- Priority: CN201611201033.8 20161222
- International Application: PCT/CN2017/117861 WO 20171222
- International Announcement: WO2018/113758 WO 20180628
- Main IPC: A61K31/4245
- IPC: A61K31/4245 ; C07D271/04 ; A61P35/04 ; A61K45/06
Abstract:
Provided in the present application are a sulfonyl amidine as represented by formula (I) as an indoleamine-2,3-dioxygenase inhibitor, and a preparation method therefor and the use thereof. The compound of formula (I) in the present application can be used as an indoleamine-2,3-dioxygenase inhibitor in the preparation of a drug for preventing and/or treating indoleamine-2,3-dioxygenase-mediated diseases.
Public/Granted literature
Information query
